AI driven labs Leverage Opentrons’ AI-enabled automation initiatives and NVIDIA collaboration to position cross-sell opportunities for AI-powered wet lab workflows, particularly to customers investing in autonomous science and AI-driven drug discovery.

Compliance ready Target institutions and biopharma labs that require validated, regulatory-friendly automation. The recent Compliance Ready Software for Opentrons Flex opens conversations with R&D and QA teams about audit trails, data integrity, and GMP-like workflows.

Protocol ecosystem Promote Opentrons’ open-source ecosystem and Protocol Visualization to labs seeking rapid protocol sharing and reproducibility. Upsell to institutions needing scalable automation with easy collaboration across distributed research teams.

Global reach Focus on universities, biopharma, and clinical research labs in multiple countries using Opentrons robots; expand footprint in markets where autonomy in automation reduces labor costs and accelerates project timelines.

Scale and integration Highlight opportunities to integrate Opentrons hardware with existing tech stack (Azure, Postman, monday.com, DocuSign) and expand services around protocol management, data capture, and workflow orchestration to drive larger multi-site deployments.